TearSolutions, Inc.

Have you been diagnosed with Primary Sjögren’s Syndrome (Primary SS)?

Do you suffer from Dry Eye associated with Primary SS?
Do you know there is a clinical trial of Lacripep™, an experimental treatment for Dry Eye in patients with Primary SS?
The goal of this trial is to restore health to the surface of your eye and treat symptoms of Dry Eye (eye dryness, burning, discomfort) in patients with Primary SS

Interested? Please check out the site nearest you and call the assigned telephone number between 9 am and 5 pm EST (Monday – Friday) or Email us. Our call in staff based in the US are ready to answer questions and assess whether you likely qualify for the trial. They will then make contact with the clinical site nearest you.

Where are the trial sites? Please scroll down or Google ‘sjogren’s syndrome dry eye‘ on your smart phone. If you are close to a clinical site, contact information will pop up.

About the Clinical Trial

The study will last 8 weeks and include 5 visits to an ophthalmologist. Patients will be provided with ophthalmic drops of Lacripep™ or placebo. Lacripep™ is a synthetic tear protein fragment of ‘lacritin’. Lacritin and a natural version of Lacripep™ are constituents of normal human tears but are lacking in dry eye tears. In preclinical studies, both restore tearing and eye health. The study purpose is to assess the effectiveness and safety of Lacripep™ in dry eye patients. The trial is FDA approved. It is listed as NCT03226444 in ClinicalTrials.gov.
The study is restricted to patients with primary Sjögren’s Syndrome dry eye. It is necessary that you stop your treatment of Restasis or Xiidra two weeks before. Those with punctal plugs inserted two weeks before or later are acceptable. Those on serum tears will need to cease treatment 30 days before.
If you think you may qualify (or have patients that qualify) and would be interested in participating in a clinical trial, please see if there is a clinical trial site close to you. The sites are listed below by state.

Questions

If unsure whether you qualify, or need help enrolling, please call Cassie 919-353-5938 or Email us.
Check out information on our Facebook page.

Clinical Site Locations

Alabama

The University of Alabama at Birmingham School of Optometry
OcCERF, Ocular Surface Research Institute of the Clinical Eye Research Facility,
121 Henry B. Peters Building, 1716 University Boulevard
Birmingham, AL 35294

Call 919-353-5938 or Email

California

Global Research Management
1510 South Central Avenue, Suite 300
Glendale, CA 91204

Call 919-943-3054 or Email

Martel Eye Medical Group
11216 Trinity River Drive
Rancho Cordova, CA 95670

Call 919-353-5938 or Email

Milton M. Hom OD, FAAO, FACAAI
1131 East Alosta Avenue
Azusa, CA 91702

Call 919-943-3054 or Email

UC Berkeley Clinical Research Center
381 Minor Hall
UC Berkeley, School of Optometry
Berkeley, CA 94720

Call 919-943-3054 or Email

Wolstan & Goldberg Eye Associates
23600 Telo Ave., Suite 100
Torrance, CA 90505

Call 919-353-5938 or Email

Colorado

Corneal Consultants of Colorado
8381 SouthPark Lane
Littleton, CO 80120

Call 919-943-3054 or Email

University of Colorado Health – Sue Anschutz-Rodgers Eye Center*
1675 Aurora Court
Aurora, CO 80045

Call 919-943-3054 or Email

Florida

Bowden Eye & Associates
7205 Bonneval Road
Jacksonville, FL 32256

Call 919-943-3398 or Email

International Eye Associates, PA
1545 Hand Ave., Suite B3
Ormond Beach, FL 32174

Call 919-943-3398 or Email

Perez Eye Center
4506 Wishart Place
Tampa, FL 33603

Call 919-943-3398 or Email

Bruce A. Segal, MD, PA
5258 Linton Blvd, Suite 302
Delray Beach, FL 33484

Call 919-943-3398 or Email

Illinois

Chicago Cornea Consultants, Ltd
1585 N. Barrington Road (Doctors Bldg 2), Building 2, Suite 502
Hoffman Estates, IL 60169 (off the campus of St. Alexius Medical Center)

Call 919-943-3054 or Email